한글목차

에피제네틱스 시장은 2023-2028년간 14억 7,778만 달러 확대되고, 예측 기간 중 연평균 복합 성장률(CAGR)은 14.75%를 나타낼 것으로 예측됩니다.

에피제네틱스 시장에 대한 전체적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등의 정보를 게재했습니다.

현재의 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전체에 관한 최신 분석을 제공합니다. 비종양성 질환에서의 에피제네틱 용도 증가, CVD 유병률 증가, 벤더간 전략적 협력 관계 증가에 의해 시장 성장이 촉진되고 있습니다.

본 조사에서는 향후 몇 년간 에피제네틱스 시장 성장을 가속하는 주요 요인으로서 생명과학 업계 기술 발전를 들고 있습니다. 또한 게놈 프로젝트 증가나 에피제네틱스 시장 개척 증가는 시장의 큰 수요로 연결될 것입니다.

목차

제1장 주요 요약

• 시장 개요

제2장 시장 구도

• 시장 생태계

제3장 시장 규모

• 시장의 정의
• 시장 부문 분석
• 시장 규모(2023년)
• 시장 전망(2023-2028년)

제4장 시장 규모 실적

• 세계의 에피제네틱스 시장(2018-2022년)
• 용도별 부문 분석(2018-2022년)
• 제품별 부문 분석(2018-2022년)
• 지역별 부문 분석(2018-2022년)
• 국가별 부문 분석(2018-2022년)

제5장 Five Forces 분석

• Five Forces 요약
• 바이어의 교섭력
• 공급 기업의 교섭력
• 신규 진출업체의 위협
• 대체품의 위협
• 경쟁 위협
• 시장 현황

제6장 시장 세분화 : 용도별

• 시장 부문
• 비교 : 용도별
• 종양학 : 시장 규모와 예측(2023-2028년)
• 비종양학 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 용도별

제7장 시장 세분화 : 제품별

• 시장 부문
• 비교 : 제품별
• 시약 : 시장 규모와 예측(2023-2028년)
• 키트 : 시장 규모와 예측(2023-2028년)
• 효소 등 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 제품별

제8장 고객 상황

• 고객 상황 개요

제9장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 북미 : 시장 규모와 예측(2023-2028년)
• 유럽 : 시장 규모와 예측(2023-2028년)
• 아시아 : 시장 규모와 예측(2023-2028년)
• 세계 기타 지역 : 시장 규모와 예측(2023-2028년)
• 미국 : 시장 규모와 예측(2023-2028년)
• 독일 : 시장 규모와 예측(2023-2028년)
• 영국 : 시장 규모와 예측(2023-2028년)
• 캐나다 : 시장 규모와 예측(2023-2028년)
• 중국 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 지역 상황별

제10장 성장 촉진요인, 과제 및 동향

• 시장 성장 촉진요인
• 시장이 해결해야 할 과제
• 성장 촉진요인과 과제의 영향
• 시장 동향

제11장 벤더 구도

• 개요
• 벤더 구도
• 혼란 상황
• 업계 리스크

제12장 벤더 분석

• 대상 벤더
• 벤더의 시장 포지셔닝
• Abcam plc
• Active Motif Inc.
• Agilent Technologies Inc.
• Bio Rad Laboratories Inc.
• Eisai Co. Ltd.
• EpiGentek Group Inc.
• F. Hoffmann La Roche Ltd.
• Illumina Inc.
• Merck KGaA
• New England Biolabs Inc.
• Pacific Biosciences of California Inc.
• PerkinElmer Inc
• QIAGEN NV
• Thermo Fisher Scientific Inc.
• Zymo Research Corp.

제13장 부록

영문목차

The epigenetics market is forecasted to grow by USD 1477.78 mn during 2023-2028, accelerating at a CAGR of 14.75% during the forecast period. The report on the epigenetics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising epigenetic applications in non-oncology diseases, increasing prevalence of CVDs, and rising strategic collaboration among vendors.

Technavio's epigenetics market is segmented as below:

By Application

• Oncology
• Non-oncology

By Product

• Reagents
• Kits
• Enzymes and others

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the technological advances in the life sciences industry as one of the prime reasons driving the epigenetics market growth during the next few years. Also, the rising number of genome projects and the increasing number of recent developments in epigenetics will lead to sizable demand in the market.

The report on the epigenetics market covers the following areas:

• Epigenetics market sizing
• Epigenetics market forecast
• Epigenetics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading epigenetics market vendors that include Abcam plc, Active Motif Inc., Agilent Technologies Inc., Bio Rad Laboratories Inc., Bio Techne Corp., Eisai Co. Ltd., Element Biosciences Inc, EpiGentek Group Inc., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Illumina Inc., Merck KGaA, New England Biolabs Inc., Novartis AG, Pacific Biosciences of California Inc., PerkinElmer Inc, Promega Corp., QIAGEN NV, Thermo Fisher Scientific Inc., Zymo Research Corp., and CellCentric Ltd.. Also, the epigenetics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global epigenetics market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global epigenetics market 2018 - 2022 ($ million)
• 4.2 Application Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ million)
• 4.3 Product Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application

• 6.1 Market segments
• Exhibit 30: Chart on Application - Market share 2023-2028 (%)
• Exhibit 31: Data Table on Application - Market share 2023-2028 (%)
• 6.2 Comparison by Application
• Exhibit 32: Chart on Comparison by Application
• Exhibit 33: Data Table on Comparison by Application
• 6.3 Oncology - Market size and forecast 2023-2028
• Exhibit 34: Chart on Oncology - Market size and forecast 2023-2028 ($ million)
• Exhibit 35: Data Table on Oncology - Market size and forecast 2023-2028 ($ million)
• Exhibit 36: Chart on Oncology - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Oncology - Year-over-year growth 2023-2028 (%)
• 6.4 Non-oncology - Market size and forecast 2023-2028
• Exhibit 38: Chart on Non-oncology - Market size and forecast 2023-2028 ($ million)
• Exhibit 39: Data Table on Non-oncology - Market size and forecast 2023-2028 ($ million)
• Exhibit 40: Chart on Non-oncology - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on Non-oncology - Year-over-year growth 2023-2028 (%)
• 6.5 Market opportunity by Application
• Exhibit 42: Market opportunity by Application ($ million)
• Exhibit 43: Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by Product

• 7.1 Market segments
• Exhibit 44: Chart on Product - Market share 2023-2028 (%)
• Exhibit 45: Data Table on Product - Market share 2023-2028 (%)
• 7.2 Comparison by Product
• Exhibit 46: Chart on Comparison by Product
• Exhibit 47: Data Table on Comparison by Product
• 7.3 Reagents - Market size and forecast 2023-2028
• Exhibit 48: Chart on Reagents - Market size and forecast 2023-2028 ($ million)
• Exhibit 49: Data Table on Reagents - Market size and forecast 2023-2028 ($ million)
• Exhibit 50: Chart on Reagents - Year-over-year growth 2023-2028 (%)
• Exhibit 51: Data Table on Reagents - Year-over-year growth 2023-2028 (%)
• 7.4 Kits - Market size and forecast 2023-2028
• Exhibit 52: Chart on Kits - Market size and forecast 2023-2028 ($ million)
• Exhibit 53: Data Table on Kits - Market size and forecast 2023-2028 ($ million)
• Exhibit 54: Chart on Kits - Year-over-year growth 2023-2028 (%)
• Exhibit 55: Data Table on Kits - Year-over-year growth 2023-2028 (%)
• 7.5 Enzymes and others - Market size and forecast 2023-2028
• Exhibit 56: Chart on Enzymes and others - Market size and forecast 2023-2028 ($ million)
• Exhibit 57: Data Table on Enzymes and others - Market size and forecast 2023-2028 ($ million)
• Exhibit 58: Chart on Enzymes and others - Year-over-year growth 2023-2028 (%)
• Exhibit 59: Data Table on Enzymes and others - Year-over-year growth 2023-2028 (%)
• 7.6 Market opportunity by Product
• Exhibit 60: Market opportunity by Product ($ million)
• Exhibit 61: Data Table on Market opportunity by Product ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 65: Chart on Geographic comparison
• Exhibit 66: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
• Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
• Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Germany - Market size and forecast 2023-2028
• Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.9 UK - Market size and forecast 2023-2028
• Exhibit 91: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibit 92: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibit 93: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.10 Canada - Market size and forecast 2023-2028
• Exhibit 95: Chart on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibit 96: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibit 97: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• 9.11 China - Market size and forecast 2023-2028
• Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 103: Market opportunity By Geographical Landscape ($ million)
• Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 105: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 107: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 108: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 109: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 110: Matrix on vendor position and classification
• 12.3 Abcam plc
• Exhibit 111: Abcam plc - Overview
• Exhibit 112: Abcam plc - Product / Service
• Exhibit 113: Abcam plc - Key news
• Exhibit 114: Abcam plc - Key offerings
• 12.4 Active Motif Inc.
• Exhibit 115: Active Motif Inc. - Overview
• Exhibit 116: Active Motif Inc. - Product / Service
• Exhibit 117: Active Motif Inc. - Key offerings
• 12.5 Agilent Technologies Inc.
• Exhibit 118: Agilent Technologies Inc. - Overview
• Exhibit 119: Agilent Technologies Inc. - Business segments
• Exhibit 120: Agilent Technologies Inc. - Key offerings
• Exhibit 121: Agilent Technologies Inc. - Segment focus
• 12.6 Bio Rad Laboratories Inc.
• Exhibit 122: Bio Rad Laboratories Inc. - Overview
• Exhibit 123: Bio Rad Laboratories Inc. - Business segments
• Exhibit 124: Bio Rad Laboratories Inc. - Key news
• Exhibit 125: Bio Rad Laboratories Inc. - Key offerings
• Exhibit 126: Bio Rad Laboratories Inc. - Segment focus
• 12.7 Eisai Co. Ltd.
• Exhibit 127: Eisai Co. Ltd. - Overview
• Exhibit 128: Eisai Co. Ltd. - Business segments
• Exhibit 129: Eisai Co. Ltd. - Key offerings
• Exhibit 130: Eisai Co. Ltd. - Segment focus
• 12.8 EpiGentek Group Inc.
• Exhibit 131: EpiGentek Group Inc. - Overview
• Exhibit 132: EpiGentek Group Inc. - Product / Service
• Exhibit 133: EpiGentek Group Inc. - Key offerings
• 12.9 F. Hoffmann La Roche Ltd.
• Exhibit 134: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 135: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 136: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 137: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 138: F. Hoffmann La Roche Ltd. - Segment focus
• 12.10 Illumina Inc.
• Exhibit 139: Illumina Inc. - Overview
• Exhibit 140: Illumina Inc. - Business segments
• Exhibit 141: Illumina Inc. - Key news
• Exhibit 142: Illumina Inc. - Key offerings
• Exhibit 143: Illumina Inc. - Segment focus
• 12.11 Merck KGaA
• Exhibit 144: Merck KGaA - Overview
• Exhibit 145: Merck KGaA - Business segments
• Exhibit 146: Merck KGaA - Key news
• Exhibit 147: Merck KGaA - Key offerings
• Exhibit 148: Merck KGaA - Segment focus
• 12.12 New England Biolabs Inc.
• Exhibit 149: New England Biolabs Inc. - Overview
• Exhibit 150: New England Biolabs Inc. - Product / Service
• Exhibit 151: New England Biolabs Inc. - Key news
• Exhibit 152: New England Biolabs Inc. - Key offerings
• 12.13 Pacific Biosciences of California Inc.
• Exhibit 153: Pacific Biosciences of California Inc. - Overview
• Exhibit 154: Pacific Biosciences of California Inc. - Product / Service
• Exhibit 155: Pacific Biosciences of California Inc. - Key offerings
• 12.14 PerkinElmer Inc
• Exhibit 156: PerkinElmer Inc - Overview
• Exhibit 157: PerkinElmer Inc - Business segments
• Exhibit 158: PerkinElmer Inc - Key news
• Exhibit 159: PerkinElmer Inc - Key offerings
• Exhibit 160: PerkinElmer Inc - Segment focus
• 12.15 QIAGEN NV
• Exhibit 161: QIAGEN NV - Overview
• Exhibit 162: QIAGEN NV - Product / Service
• Exhibit 163: QIAGEN NV - Key news
• Exhibit 164: QIAGEN NV - Key offerings
• 12.16 Thermo Fisher Scientific Inc.
• Exhibit 165: Thermo Fisher Scientific Inc. - Overview
• Exhibit 166: Thermo Fisher Scientific Inc. - Business segments
• Exhibit 167: Thermo Fisher Scientific Inc. - Key news
• Exhibit 168: Thermo Fisher Scientific Inc. - Key offerings
• Exhibit 169: Thermo Fisher Scientific Inc. - Segment focus
• 12.17 Zymo Research Corp.
• Exhibit 170: Zymo Research Corp. - Overview
• Exhibit 171: Zymo Research Corp. - Product / Service
• Exhibit 172: Zymo Research Corp. - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 173: Inclusions checklist
• Exhibit 174: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 175: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 176: Research methodology
• Exhibit 177: Validation techniques employed for market sizing
• Exhibit 178: Information sources
• 13.5 List of abbreviations
• Exhibit 179: List of abbreviations